Clinical trial
Stem Cell Isolation From Femoral Heads Post Total Hip Arthroplasty
Opening soon · Not applicable · 0 countries · Registry ID NCT06775600
What this study is about
Femoral heads will be collected at University Hospital (London, ON, Canada) from individuals with type-2 diabetes, obesity, and no T2D/no obesity controls. The femoral head will be taken to the Robarts Research Institute (London, ON, Canada) for lineage-restricted progenitor cell expansion and analyses. There the femoral heads will be used to isolate three stem cell types - Multipotent Stromal Cells, Endothelial Colony Forming Cells, and Hematopoietic Progenitor Cells. The yield and cell surface markers expressed on these cells will be measured using flow cytometry. These cell types will then undergo further analyses of the secretome, tubule forming assays, vascular regenerative cell exhaustion assays, and will be transplanted into immune deficient mice with with femoral artery ligation. These experiments are to assess the differences in function and expression of these cell types between individuals with type-2 diabetes and/or obesity and/or healthy controls.
Basic eligibility
Full registry criteria
Treatments and study arms
Hip Replacement
Total Hip Arthroplasty where the Femoral Head will be used to harvest stem cells post-extrication from the individual.
Primary outcomes
Quantification of how many cells are harvested from each femoral head prior to expansion in vitro
Quantification of the Growth Kinetics of each cell type during in vitro cell culture post cell harvest.
Analysis via flow cytometry of the phenotype of each cell type and their respective surface markers that are involved in regenerative pathways.
Study locations
0 locations were listed when this page was built. The first 40 are shown.